Skip to main content
. 2024;78(1):12–15. doi: 10.5455/medarh.2024.78.12-15

Table 2. Cross tabulation between PSA and histopathological findings.

Histopathological findings Total
BPH Prostat Cancer
PSA ≥ Cut-off 11(20,8%) 9(17,0%) 20(37,7%)
PSA ≤ Cut-off 29(54,7%) 4(7,5%) 33(62,3%)
Total 40(24,5%) 13(24,5%) 53(100%)